Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Abbott Laboratories (NYSE:ABT)

Paying users zone. Data is hidden behind: .

  • Get 1-month access to Abbott Laboratories for $19.99, or

  • get full access to the entire website for at least 3 months from $49.99.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Abbott Laboratories pages available today for free:

Income Statement
Quarterly Data

Beginner level

The income statement presents information on the financial results of a company’s business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Abbott Laboratories, consolidated income statement (quarterly data)

US$ in millions

Microsoft Excel LibreOffice Calc
3 months ended: Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Net sales
Cost of products sold, excluding amortization of intangible assets
Amortization of intangible assets
Gross profit
Research and development
Selling, general and administrative
Operating earnings (loss)
Interest expense
Interest income
Net foreign exchange gain (loss)
Net loss on extinguishment of debt
Other income (expense), net
Earnings (loss) from continuing operations before tax
Tax (expense) benefit on earnings (loss) from continuing operations
Earnings (loss) from continuing operations
Earnings (loss) from discontinued operations, net of tax
Gain (loss) on sale of discontinued operations, net of tax
Net earnings (loss) from discontinued operations, net of tax
Net earnings (loss)

Based on: 10-Q (filing date: 2020-07-29), 10-Q (filing date: 2020-04-29), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-10-31), 10-Q (filing date: 2019-07-31), 10-Q (filing date: 2019-05-01), 10-K (filing date: 2019-02-22), 10-Q (filing date: 2018-10-31), 10-Q (filing date: 2018-08-01), 10-Q (filing date: 2018-05-02), 10-K (filing date: 2018-02-16), 10-Q (filing date: 2017-11-02), 10-Q (filing date: 2017-08-02), 10-Q (filing date: 2017-05-03), 10-K (filing date: 2017-02-17), 10-Q (filing date: 2016-11-03), 10-Q (filing date: 2016-08-03), 10-Q (filing date: 2016-05-04), 10-K (filing date: 2016-02-19), 10-Q (filing date: 2015-11-05), 10-Q (filing date: 2015-08-04), 10-Q (filing date: 2015-05-06).

Income statement item Description The company
Net sales Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Abbott Laboratories’s net sales decreased from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.
Operating earnings (loss) The net result for the period of deducting operating expenses from operating revenues. Abbott Laboratories’s operating earnings (loss) decreased from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.
Earnings (loss) from continuing operations before tax Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Abbott Laboratories’s earnings (loss) from continuing operations before tax decreased from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.
Net earnings (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Abbott Laboratories’s net earnings (loss) decreased from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020.